Aerie’s glaucoma drug journey ends in $770M sale to Alcon
Bio Pharma Dive
AUGUST 23, 2022
The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales.
Drugs Marketing Sales 
Lilly market value soars on higher sales, obesity drug potential
Bio Pharma Dive
AUGUST 8, 2023
The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.
Marketing 
246
246 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Novartis prostate cancer drug succeeds in study key to company’s sales hopes
Bio Pharma Dive
DECEMBER 5, 2022
The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market.
Sales 301
301 
Novartis sales of Zolgensma gene therapy slow as market shifts
Bio Pharma Dive
OCTOBER 25, 2022
Treatment is now mostly of infants newly diagnosed with spinal muscular atrophy, as many of those previously eligible either already received Zolgensma or other drugs from Biogen and Roche.
Gene Therapy 293
293 
Novo shares tumble on lower-than-expected obesity drug sales
Bio Pharma Dive
AUGUST 7, 2024
Quarterly revenue from Ozempic and Wegovy missed Wall Street estimates by about 9%, concerning some analysts and causing a stock sell-off costing the Danish drugmaker tens of billions in market value.
Sales 279
279 
The debate on DTC marketing is going to heat up again
World of DTC Marketing
JULY 21, 2021
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.
Marketing 285
285 
Acorda files for bankruptcy, reveals asset sale plan
Bio Pharma Dive
APRIL 2, 2024
Stalking horse bidder Merz Therapeutics could get rights to Acorda’s three marketed drugs if its $185 million proposal holds.
Sales 300
300 
Amylyx’s ALS drug sales impress Wall Street
Bio Pharma Dive
MARCH 13, 2023
In its first full quarter on the market, Amylyx’s Relyvrio generated revenue just shy of $22 million, or roughly five times what some analysts were forecasting a month ago.
Sales 238
238 
Why hasn’t pharma embraced email marketing?
World of DTC Marketing
MARCH 9, 2021
SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.
Marketing 289
289 
DTC marketing is an oxymoron
World of DTC Marketing
APRIL 22, 2021
QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. I’ve spent the last six months analyzing clients’ DTC marketing campaigns and they are, for most ineffective. One of the most underused tactics is your product website.
Marketing 265
265 
Pfizer forecasts steep decline in COVID vaccine, drug sales
Bio Pharma Dive
JANUARY 31, 2023
The company expects yearly revenue from Comirnaty and Paxlovid to fall by nearly two thirds in 2023 amid lower vaccination rates and a shift to private market sales.
Sales 167
167 
HCPs sound off on pharma marketing
World of DTC Marketing
APRIL 20, 2022
We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. ” We heard more negative comments than positive ones from sales reps, even in Oncology. This was especially true with new drugs that have a significant competitive market.
Marketing 218
218 
Medical devices industry asks govt to define and bring clarity on online sale of devices in New Drugs Bill, 2022
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 14, 2022
The medical devices industry in the country has sought the Centre to define online and offline mode of sale, provide more clarity on the regulations that are binding the online sales and suggested inclusion of online medical devices players under the Uniform Code for Medical Devices Marketing Practices (UCMDMP).
Sales 182
182 
Pharma: The time is now for digital marketing
World of DTC Marketing
JANUARY 14, 2021
SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. To master digital marketing, pharma needs to be prepared to fail. Will digital replace the sales force?
Marketing 180
180 
Merck acquires cancer drug startup; Elevidys ex-US sales rise
Bio Pharma Dive
OCTOBER 23, 2024
Elsewhere, Sangamo plotted a much faster path to market for its Fabry gene therapy. Yale spinout Modifi agreed to sell to Merck for $30 million upfront.
Gene Therapy 190
190 
GSK, Pfizer, Sanofi shares drop amid Zantac litigation concerns
Bio Pharma Dive
AUGUST 11, 2022
The companies could face liability related to their sales of the heartburn drug, which was withdrawn from market in the U.S. and other countries after impurities related to a likely carcinogen were detected.
Sales 284
284 
Entrance of novel therapies will drive Niemann-Pick type C disease market growth
Pharmaceutical Technology
JULY 26, 2022
According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.
Marketing 306
306 
The Brazilian pharma market: Key information and what may change
Pharmaceutical Technology
DECEMBER 9, 2022
Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Brazilian public spending on healthcare, drug pricing reforms and remote medicine.
Marketing 246
246 
The four biggest challenges facing DTC marketers
World of DTC Marketing
APRIL 6, 2022
DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Paid Media – The most commonly used KPI in marketing is essentially worthless.
Marketing 196
196 
Biogen and its partner rework terms of Aduhelm deal amid slow sales
Bio Pharma Dive
MARCH 15, 2022
Instead of sharing global profits and losses, Eisai will receive royalties tied to net sales of the Alzheimer's drug. Biogen, meanwhile, said the amended deal should make it easier to "address market developments."
Sales 157
157 
Biohaven migraine drug sales again top Wall Street forecasts
Bio Pharma Dive
OCTOBER 6, 2021
The neuroscience-focused biotech continues to win market share in a battle with some of the industry's largest companies.
Sales 184
184 
Marketing Your Patented Drug Effectively: Strategies for Maximizing Patent Protection and Exclusivity
Drug Patent Watch
JANUARY 30, 2025
Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. This exclusivity is a result of the patent protection granted to the drug's developer. Read the full article here: [link]
Marketing 54
54 
Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition
Pharmaceutical Technology
JANUARY 25, 2023
It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.
Sales 147
147 
Roche eye drug sales grow as Regeneron plays catch-up
Bio Pharma Dive
OCTOBER 19, 2023
market share for its new AMD drug Vabysmo as Regeneron tries to rebound from a now-resolved delay for its high-dose Eylea. The Swiss pharma reported expanding U.S.
Sales 157
157 
Warnings for Japanese pharmaceutical market may lead to more lenient price controls
Pharmaceutical Technology
NOVEMBER 21, 2022
Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Other reasons include lower sales demand and high investment costs.
Marketing 173
173 
Pharma is “big business” that uses excuses to keep prices high
World of DTC Marketing
OCTOBER 5, 2021
SUMMARY: Americans spend twice as much per capita on drugs as residents of other wealthy nations, because ours is the only country that lets drugmakers set any price they want for their products. Via Axios “The 10 highest-selling drugs in the U.S. sales of the 20 top-selling drugs worldwide totaled $101.1
Sales 241
241 
Biden proposes subsidizing drug middlemen for insulin
World of DTC Marketing
MARCH 31, 2022
Essentially taxpayers would be subsidizing drug company profits for the price of a product that should have come down a long time ago. Research shows that the three-drug companies that dominate global insulin sales — Novo Nordisk, Eli Lilly, and Sanofi may not be entirely to blame for the soaring costs to people with diabetes.
Insulin 240
240 
Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023
Pharmaceutical Technology
APRIL 28, 2023
Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Originally granted approval in its largest market, the US, in 2017, Ozempic has subsequently obtained approval for three distinct dosages, 0.5mg, 1.0mg, and 2.0mg, for the treatment of type 2 diabetes.
Sales 130
130 
Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division
Bio Pharma Dive
APRIL 9, 2025
market, bladder cancer treatment Adstiladrin earned about $77 million. Elsewhere, Lilly backed a cancer drug startup and Bristol Myers won a new Opdivo approval. In its first full year on the U.S.
Gene Therapy 144
144 
How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing
Drug Patent Watch
DECEMBER 12, 2024
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.
Licensing 94
94 
The obesity drug effect: What medical device executives are saying
Bio Pharma Dive
NOVEMBER 2, 2023
Stock selloffs across the medical device sector have erased hundreds of billions of dollars in market value. But medtech executives argue GLP-1 drug demand will complement, not cannibalize, their sales.
Drugs 167
167 
From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep
Fierce Pharma
JUNE 17, 2024
Two back-to-back pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could reach more than 3 billion pounds sterling in peak sales after all. |
Sales 108
108 
AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes
World of DTC Marketing
JULY 8, 2022
In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes. prescription drug sales signals that big pharma will do anything to avoid hurting profits. The maneuvers employed by AbbVie to avoid paying U.S.
Sales 269
269 
HCPs use of digital
World of DTC Marketing
JULY 28, 2021
The value proposition to HCP marketers is different from the value proposition that physicians want. When I worked on an Oncology drug, we included a forum where physicians could post questions to thought leaders on the drug. As new drugs are seeded in the market, the information needs of physicians change.
Doctor 313
313 
Enabling the next wave of innovative drug therapies with speciality enzymes
Pharmaceutical Technology
JUNE 29, 2022
The pharmaceutical industry often relies on enzymes to perform a process known as biocatalysis, which facilitates the cost-effective and sustainable production of small molecule drugs at scale. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.
Drugs 295
295 
Roche’s new eye drug pressures Eylea with strong launch
Bio Pharma Dive
APRIL 26, 2023
One year after its market debut, the company’s AMD drug Vabysmo is on track for blockbuster sales as Regeneron’s rival treatment faces new threats.
Drugs 157
157 
CagriSema, Novo Nordisk’s Latest Obesity Drug Offering, Disappoints Investors with Trial Results
XTalks
MARCH 14, 2025
Novo Nordisks investigational obesity combination drug, CagriSema (a fixed dose combination of cagrilintide 2.4 Novo shared the latest data from the Phase III REDEFINE 2 trial evaluating the drug in overweight or obese patients with type 2 diabetes. mg and semaglutide 2.4 after 68 weeks compared to 3.1% with placebo. with placebo.
Trials 89
89 
Gilead wins patent battle with US government over HIV PrEP drugs
Pharmaceutical Technology
MAY 10, 2023
Gilead Sciences has emerged victorious in a legal battle with the US government over patents surrounding the HIV pre-exposure prophylaxis (PrEP) drugs Descovy and Truvada following a federal jury’s verdict on May 9. Gilead markets both Truvada and its successor Descovy. GlobalData is the parent company of Pharmaceutical Technology.
Drugs 264
264 
BMS: Delayed new drug to avoid paying billions?
World of DTC Marketing
FEBRUARY 25, 2022
billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec.
Drugs 216
216 
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate
Fierce Pharma
APRIL 23, 2024
The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. | The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales.
Marketing 101
101 
Novo Nordisk, Eli Lilly's obesity drugs will lead in new drug sales in 2024: Evaluate
Fierce Pharma
JANUARY 3, 2024
Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales.
Sales 103
103 
Launching a new drug: How much to spend on DTC?
World of DTC Marketing
SEPTEMBER 30, 2020
HERE”S THE DEAL: Determining how much to spend for the launch of a new drug is a challenge we all face and you have to be ready to shift funds from channels that are failing to provide the lift in brand awareness to channels that hit the bullseye on your objectives. 2wo: An in-depth knowledge of the market segments.
Drugs 180
180 
Let's personalize your content